Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in ANRO — Alto Neuroscience, Inc.

CIK 80255 BALTIMORE, MD
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,454,982
+$1,110,227 QoQ
Shares Held
358,279
-3.5% QoQ
Ownership
0.913%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 114 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ANRO ranks #122 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in ANRO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,454,982 358,279
2026-03-31 $8,344,755 371,208
2025-12-31 $538,058 30,228
2025-09-30 $238,900 59,428
2025-06-30 $130,741 59,428
2025-03-31 $116,486 53,929
2024-12-31 $3,573,600 844,823
2024-09-30 $9,249,285 808,504
2024-06-30 $6,903,943 645,832
2024-03-31 $9,787,221 637,604